Last updated: April 9, 2024
Sponsor: China Medical University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Menstrual Disorders
Female Hormonal Deficiencies/abnormalities
Severe Premenstrual Symptom
Treatment
Placebo
Nuan-gong-ye
Clinical Study ID
NCT06295822
CMUH112-REC2-063
Ages 20-40 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 20-40 year-old women
- Regular menstrual cycle of 21-35 days, with menstruation lasting 3-7 days
- Dysmenorrhea started before the age of 20, and have menstrual pain every month
- No organic lesions on ultrasound within one year (either abdomen or vagina)
- VAS score above 4
- Agree to participate in the study and sign the consent form
Exclusion
Exclusion Criteria:
- Has used the same formula of Nuan-gong-ye before.
- Allergic to Nuan-gong-ye.
- Has abdominal wounds, infections, or skin diseases.
- Pregnant or planning to become pregnant within the next five months.
- Has taken traditional Chinese medicine or prescribed medication for menstrual pain bya Chinese medicine doctor in the past month.
- Has major illnesses defined by the Taiwan National Health Insurance Administration,such as cancer, heart disease, etc.
- Has mental illness or cognitive impairment and cannot independently fill out thequestionnaire.
- Has a history of epilepsy or pelvic disorders.
Study Design
Total Participants: 82
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
March 04, 2024
Estimated Completion Date:
February 28, 2026
Study Description
Connect with a study center
China Medical University Hospital
Taichung, 404
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.